Mtar Technologies Limited (MTARTECH) Q2 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch

MTAR Technologies makes mission-critical precision components for clean energy (civil nuclear, fuel cells), aerospace and defence, and enters this quarter on the back of a record Q1 with revenue up 130.4% YoY. The Q2 print will speak to whether the 80% FY27 growth path and the 24% ±100 bps EBITDA margin band hold, and whether nuclear refurbishment inflows of Rs. 130-140 Cr guided into this quarter materialise.

Mtar Technologies Limited Q2 Results Date and Time

The board meeting is scheduled to consider the Q2/H1 FY27 results on 29 Oct 2026, 3:00 pm, in Hyderabad. The trading window remains closed until 48 hours after the results.

What to expect from Mtar Technologies Limited's Q2 FY27 results

The Q2 FY27 print will test whether MTAR's 80% FY27 revenue growth guidance and 24% ±100 bps EBITDA margin band stay intact, against a very soft year-ago base of Rs. 135.6 Cr revenue and a 12.5% EBITDA margin in Q2 FY26. The dominant driver is the fuel-cell franchise: tier-1 customer Bloom Energy reported record Q3'26 (Jul-Sep 2026) revenue of $1,235.8 Mn, up 138.1% YoY, with FY26 guidance raised again on Oct 22, 2026, while MTAR's SOFC line runs at 100% utilisation with capacity ramping to 16,000 units by September 2026. On nuclear, disclosed Q2 inflow of Rs. 126.74 Cr from NPCIL (26 Aug 2026) lands just below the Rs. 130-140 Cr guided specifically into Q2, with the closing nuclear order book above Rs. 775 Cr — the highest in company history. The tariff overhang with the US never resolved during the quarter — a 10% duty on India took effect 24 Jul 2026 and talks remained unresolved into October — so a repeat of the year-ago execution stall is a live risk management has flagged before. Execution capacity, not demand, remains the binding constraint against a pro-forma order book of Rs. 5,943 Cr, and the call is expected to cover milestone updates on the Oil & Gas facility (operational by October 2026), the Rs. 500 Cr two-year capex funding mix, and whether guidance is raised again.

Key Things To Watch

Guidance tracking (FY27 targets): Key FY27 targets set the bar for this call:

• Revenue growth — 80% — FY27: Q1 FY27 grew 130.4% YoY; watch whether the H1 run-rate keeps the company ahead of the 80% trajectory (implied FY27 revenue about Rs. 1,577.16 Cr at the 80% point estimate)
• EBITDA margin — 24% ±100 bps — FY27: Q1 printed 23.6%; watch the Q2 print against the band, especially against a weak 12.5%-margin Q2 FY26 base
• Nuclear refurbishment orders — Rs. 130-140 Cr — in Q2 FY27 (this quarter): directly testable on this call; Rs. 126.74 Cr already confirmed on 26 Aug 2026
• Closing order book — Rs. 5,000 Cr — by end FY27: already exceeded at Q1 end (Rs. 5,143 Cr, plus Rs. 800 Cr same-day); watch incremental inflows including the amended USD 324.62 Mn export order and nuclear book above Rs. 775 Cr
• Fuel cell capacity — multifold expansion by March 2027; interim milestones: 16,000 units by September 2026 and 20,000 by March FY27
• Oil & Gas facility — operational by October 2026; peak revenue potential Rs. 450-500 Cr over 3-4 years
• Aerospace & Defence revenue — double — FY27; LCA Tejas Mark-1A actuator volume orders (program Rs. 140-150 Cr) still anticipated as of Q1 FY27
• Working capital — about 100 days by FY27 year-end (59 days at Q1); ROCE — 23% — next year; capex — Rs. 500 Cr over next two years with funding plan (debt vs accruals vs external capital) open

Strategic initiative updates

• Data centre infrastructure facility and SLB ramp — Rs. 35 Cr of orders secured, with management sizing the AI data centre opportunity at Rs. 400-500 Cr
• NCLT merger scheme progress for Gee Pee Aerospace and Magnatar Aero Systems into MTAR Technologies
• Fluence agreement status (long-term agreement targeted by Q4 FY26) and AMCA bid outcome (decision expected around May 2026)

Risks and headwinds to monitor

• Execution capacity vs the Rs. 5,943 Cr pro-forma order book — management has said the primary constraint is expanding capabilities, not securing orders
• Nuclear order timing — management: 'it depends on the timing of the tenders and when the department would release the orders'
• Any residual tariff effects on exports — prolonged tariff discussions delayed execution by roughly three to three-and-a-half weeks in Q2 FY26